Grade Summary: Delaware
Tobacco Prevention Control and Spending
- FY2013 State Funding for Tobacco Control Programs: $9,021,800
- FY2013 Federal Funding for State Tobacco Control Programs: $821,064*
- FY2013 Total Funding for State Tobacco Control Programs: $9,842,864
- CDC Best Practices State Spending Recommendation: $13,900,000
- Percentage of CDC Recommended Level: 70.8%
*Includes tobacco prevention and cessation funding provided to states from the Centers for Disease Control and Prevention and U.S. Food and Drug Administration.
Smokefree Air
Overview of State Smoking Restrictions
- Government Workplaces: Prohibited
- Private Workplaces: Prohibited
- Schools: Prohibited
- Childcare Facilities: Prohibited
- Restaurants: Prohibited
- Bars: Prohibited
- Casinos/Gaming Establishments: Prohibited
- Retail Stores: Prohibited
- Recreational/Cultural Facilities: Prohibited
- Penalties: Yes
- Enforcement: Yes
- Preemption: No
Citation: DEL. CODE ANN. tit. 16, §§ 2901 et seq. (2002).
Cigarette Tax
- Tax rate per pack of 20: $1.60
Cessation
Overview of State Cessation Coverage
State Medicaid Program:
- Medications: Covers all 7 recommended cessation medications*
- Counseling: Covers individual counseling
- Barriers to Coverage: Prior authorization, use of some medications before using others, use of counseling to get medications and minimal copayments required
State Employee Health Plan(s):
- Medications: Covers NRT Nasal Spray, NRT Inhaler, Varenicline (Chantix) and Bupropion (Zyban)
- Counseling: Covers individual, group, phone and online counseling
- Barriers to Coverage: Annual limits on treatment and limits on duration
State Quitline:
- Investment Per Smoker: $7.30; CDC recommends an investment of $10.53
Other Cessation Provisions:
- Private Insurance Mandate: No provision
Citation: See State Tobacco Cessation Coverage page for specific sources.
* The 7 recommended cessation medications are: NRT Gum, NRT Patch, NRT Nasal Spray, NRT Inhaler, NRT Lozenge, Varenicline (Chantix) and Bupropion (Zyban).




